Related Experiment Videos
Heparin versus hirudin for acute coronary syndromes
The New England Journal of Medicine
|March 6, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Assessment of whole blood coagulation with a microfluidic dielectric sensor.
Journal of thrombosis and haemostasis : JTH·2018
Plasma kallikrein activates the epithelial sodium channel in vitro but is not essential for volume retention in nephrotic mice.
Acta physiologica (Oxford, England)·2018
The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
Journal of thrombosis and haemostasis : JTH·2015
Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor).
Current molecular medicine·2014
Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH.
Journal of thrombosis and haemostasis : JTH·2013
Modulation of the cell membrane expression of the kininogens regulates the rate of bradykinin delivery to cells.
Trends in cardiovascular medicine·2011
Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis.
The New England journal of medicine·2026
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
The New England journal of medicine·2026
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.
The New England journal of medicine·2026
Eplontersen for Transthyretin Amyloid Cardiomyopathy.
The New England journal of medicine·2026
Myeloproliferative Neoplasms.
The New England journal of medicine·2026
Prognostic Role of Blood Inflammatory Composite Biomarkers in Dvt After Lower Extremity Fractures.
The Iowa orthopaedic journal·2026
Pattern of blood utilization and blood wastage at blood bank of a tertiary care hospital in Lahore.
Pakistan journal of medical sciences·2026
Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial.
Research and practice in thrombosis and haemostasis·2026
Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies.
Research and practice in thrombosis and haemostasis·2026